| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Other
|
Saccharomyces cerevisiae
|
David Baker
|
Jun 26, 2024
|
||||
| GSE263250 |
Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins
|
|
|
34 | David Baker | Jun 26, 2024 |
